Skip to main content

triple negative breast cancer Archives

Targeting the “un-targetable”

Nov. 18, 2016—A novel drug that targets the protein RSK blocked aggressive breast cancers from metastasizing in an animal model.

Read more

Health and Medicine Reporter Research


In search of new cancer targets

Sep. 9, 2016—Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

Read more

Health and Medicine Reporter Research


Study explores how some breast cancers resist treatment

Apr. 21, 2016—A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

Read more

Health and Medicine Healthcare Solutions Reporter Research


New target for breast cancer therapy

Jul. 31, 2014—The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics.

Read more

Health and Medicine Reporter Research


Breast cancer study explores therapy to slow recurrence

Mar. 21, 2013—Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer.

Read more

Health and Medicine Reporter Research


Vanderbilt cancer investigators win two national GE cancer research grants

Mar. 28, 2012—Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.”

Read more

External Story Health and Medicine Research


Different types of aggressive breast cancer identified

Jun. 28, 2011—Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of an aggressive and difficult-to-treat form of breast cancer.

Read more

Health and Medicine Research